注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
TransCode Therapeutics Inc是一家生物製藥公司,專注於開發和商業化治療轉移性疾病的藥物。該公司已經開發了一種模塊化的、基於氧化鐵納米顆粒的納米載體系統,用於向腫瘤輸送RNA療法。該公司的主要候選治療藥物TTX-MC138以microRNA-10b(miRNA-10b)為靶點,microRNA-10b是乳腺癌、胰腺癌、卵巢癌、結腸癌、膠質母細胞瘤等多種癌症轉移細胞活力的主要調節因子。其臨床前項目包括兩個實體瘤項目,如TTX-siPDL1,其為一種基於小干擾RNA(siRNA)的程序性死亡配體1(PD-L1)調節劑,和TTX-siLin28b,其為一種基於siRNA的RNA結合蛋白LIN28B抑製劑。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Anna Moore | 61 | 2016 | Co-Founder, Scientific Advisor & Member of Scientific Advisory Board |
Dejan Juric | - | 2021 | Member of Advisory Board |
Raghu Kalluri | - | - | Member of Advisory Board |
Oliver Steinbach | - | - | Member of Advisory Board |
G. Susan Srivatsa | - | - | Member of Advisory Board |
Keith T. Flaherty | 53 | - | Member of Advisory Board |
George Calin | - | - | Member of Advisory Board |
Raul Mostoslavsky | - | - | Member of Advisory Board |
Magda Marquet | 65 | 2021 | Independent Director |
Erik Manting | 53 | 2020 | Independent Director |
Betsabeh Madani Hermann | - | - | Member of Advisory Board |
Lubomir Nechev | - | 2021 | Member of Advisory Board |
Philippe P. Calais | 65 | 2018 | Executive Chairman of the Board |
Dmitry Samarsky | 57 | - | Member of Advisory Board |
Mehmet Yigit | - | - | Member of Advisory Board |
Jerome M. Lewis | 75 | - | Member of Advisory Board |
John B. Henneman | 62 | - | Member of Advisory Board |
Frank J. Slack | - | 2022 | Member of Advisory Board |
Thomas A. Fitzgerald | 72 | 2018 | Interim CEO, CFO, President, VP of Administration & Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核